Invest In Psychedelic Therapy?
Psychedelic Therapy Clinics are popping up all over LA and Arizona. Some of them charge up to $2,000 for a full treatment... this is an emerging trend every investor should consider.
Tell Me More About Psychedelic Therapy

ARPO Insider Trading (Aerpio Pharmaceuticals)

Insider Ownership Percentage: 7.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $41,944.00

Aerpio Pharmaceuticals Insider Trading History Chart

Aerpio Pharmaceuticals Share Price & Price History

$1.83
▲ +0.015 (0.83%)
As of 06/22/2021 01:20 PM ET
Days: 30 | 90 | 365
Revealed: A Real Solution for Depression?
Depression is the leading cause of disability worldwide. For nearly 100 million people… there's no known solution. That's right. Nearly one-third of the world's 322 million people suffering from depression have no existing treatment. But that's all about to change.
Here's how you could capitalize off this

Aerpio Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/8/2020Orbimed Advisors LlcMajor ShareholderSell21,400$1.96$41,944.00View SEC Filing Icon  
7/10/2019Joseph H GardnerPresidentBuy5,000$0.81$4,050.00View SEC Filing Icon  
7/3/2019Joseph H GardnerPresidentBuy5,000$0.90$4,500.00View SEC Filing Icon  
4/26/2019Bioventures Ltd NovartisMajor ShareholderSell701,800$1.03$722,854.00View SEC Filing Icon  
4/24/2019Bioventures Ltd NovartisMajor ShareholderSell51,057$1.02$52,078.14View SEC Filing Icon  
4/15/2019Bioventures Ltd NovartisMajor ShareholderSell117,140$1.05$122,997.00View SEC Filing Icon  
4/10/2019Bioventures Ltd NovartisMajor ShareholderSell200,746$1.07$214,798.22View SEC Filing Icon  
4/5/2019Bioventures Ltd NovartisMajor ShareholderSell130,594$0.99$129,288.06View SEC Filing Icon  
4/2/2019Bioventures Ltd NovartisMajor ShareholderSell231,763$0.94$217,857.22View SEC Filing Icon  
3/28/2019Bioventures Ltd NovartisMajor ShareholderSell317,346$0.99$314,172.54View SEC Filing Icon  
1/10/2019Muneer A SatterDirectorBuy63,818$2.35$149,972.30View SEC Filing Icon  
1/7/2019Muneer A SatterDirectorBuy60,000$2.12$127,200.00View SEC Filing Icon  
1/2/2019Muneer A SatterDirectorBuy60,000$1.80$108,000.00View SEC Filing Icon  
12/27/2018Muneer A SatterDirectorBuy60,000$1.74$104,400.00View SEC Filing Icon  
12/20/2018Muneer A SatterDirectorBuy60,000$1.92$115,200.00View SEC Filing Icon  
12/14/2018Muneer A SatterDirectorBuy60,000$2.02$121,200.00View SEC Filing Icon  
12/11/2018Muneer A SatterDirectorBuy60,000$2.12$127,200.00View SEC Filing Icon  
12/6/2018Muneer A SatterDirectorBuy60,000$2.09$125,400.00View SEC Filing Icon  
11/30/2018Muneer A SatterDirectorBuy60,000$1.98$118,800.00View SEC Filing Icon  
11/12/2018Stephen J HoffmanCEOBuy31,967$2.01$64,253.67View SEC Filing Icon  
8/20/2018Bioventures Ltd NovartisMajor ShareholderSell5,300$3.90$20,670.00View SEC Filing Icon  
6/28/2018Muneer A SatterDirectorBuy1,818,182$3.85$7,000,000.70View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aerpio Pharmaceuticals (NASDAQ:ARPO)

56.26% of Aerpio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aerpio Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2021Citadel Advisors LLC122,770$0.16M0.0%+49.5%0.259%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC82,306$0.11M0.0%-51.9%0.174%Search for SEC Filing on Google Icon
5/18/2021Opaleye Management Inc.1,000,000$1.29M0.2%N/A2.114%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC122,770$0.16M0.0%+49.5%0.259%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC71,500$92K0.0%+500.8%0.151%Search for SEC Filing on Google Icon
5/17/2021CSS LLC IL50,000$64K0.0%N/A0.106%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD253,700$0.33M0.0%N/A0.536%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC2,072,782$2.67M0.1%N/A4.381%Search for SEC Filing on Google Icon
5/17/2021Scion Asset Management LLC1,000,000$1.29M0.1%N/A2.114%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC2,651,093$3.42M0.1%+457.2%5.603%Search for SEC Filing on Google Icon
5/14/2021Parkman Healthcare Partners LLC1,001,189$1.29M0.3%+278.7%2.116%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC1,941,538$2.51M0.0%+7.9%4.104%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC258,974$0.33M0.0%+70.6%0.547%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC1,911,478$2.47M0.0%+26.6%4.040%Search for SEC Filing on Google Icon
4/13/2021Keudell Morrison Wealth Management30,694$40K0.0%N/A0.065%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC171,089$0.17M0.0%+363.1%0.363%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC475,778$0.47M0.0%-87.9%1.010%Search for SEC Filing on Google Icon
2/11/2021Satter Management CO. L.P.5,621,835$5.51M2.2%N/A11.933%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC1,799,044$1.76M0.0%+21.1%3.819%Search for SEC Filing on Google Icon
2/10/2021Panagora Asset Management Inc.44,630$44K0.0%N/A0.095%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC36,946$55K0.0%N/A0.078%Search for SEC Filing on Google Icon
11/17/2020Jane Street Group LLC20,308$30K0.0%N/A0.043%Search for SEC Filing on Google Icon
11/16/2020Boothbay Fund Management LLC415,926$0.62M0.0%N/A0.883%Search for SEC Filing on Google Icon
11/12/2020Arrowstreet Capital Limited Partnership35,725$54K0.0%N/A0.085%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC1,180,834$1.77M0.0%N/A2.807%Search for SEC Filing on Google Icon
11/3/2020Lindbrook Capital LLC30,000$45K0.0%N/A0.071%Search for SEC Filing on Google Icon
9/10/2020Two Sigma Securities LLC24,669$31K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/13/2020Johnson Investment Counsel Inc.320,536$0.40M0.0%N/A0.790%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.29,407$37K0.0%N/A0.072%Search for SEC Filing on Google Icon
8/10/2020HighTower Advisors LLC35,500$46K0.0%-41.8%0.087%Search for SEC Filing on Google Icon
2/14/2020Goldman Sachs Group Inc.818,481$0.51M0.0%-43.1%2.017%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC407,125$0.25M0.0%+153.8%1.003%Search for SEC Filing on Google Icon
8/15/2019Jane Street Group LLC44,693$41K0.0%+200.1%0.110%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.1,300,889$1.18M0.0%+9.1%3.205%Search for SEC Filing on Google Icon
8/13/2019BlackRock Inc.165,222$0.15M0.0%+78.8%0.407%Search for SEC Filing on Google Icon
8/13/2019US Bancorp DE50,000$46K0.0%N/A0.123%Search for SEC Filing on Google Icon
8/13/2019Alambic Investment Management L.P.49,763$45K0.0%-47.3%0.123%Search for SEC Filing on Google Icon
8/9/2019Panagora Asset Management Inc.64,074$58K0.0%+390.2%0.158%Search for SEC Filing on Google Icon
8/8/2019Acadian Asset Management LLC186,550$0.17M0.0%+23.2%0.460%Search for SEC Filing on Google Icon
5/9/2019Alambic Investment Management L.P.94,500$85K0.0%N/A0.233%Search for SEC Filing on Google Icon
2/15/2019Jane Street Group LLC81,984$0.14M0.0%+216.3%0.202%Search for SEC Filing on Google Icon
2/14/2019CVI Holdings LLC166,113$0.28M0.6%-42.7%0.409%Search for SEC Filing on Google Icon
2/14/2019HarbourVest Partners LLC144,712$0.25M0.1%N/A0.357%Search for SEC Filing on Google Icon
2/12/2019Citigroup Inc.241,964$0.41M0.0%N/A0.596%Search for SEC Filing on Google Icon
2/11/2019Bank of New York Mellon Corp21,377$36K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/7/2019Acadian Asset Management LLC16,421$28K0.0%N/A0.040%Search for SEC Filing on Google Icon
12/13/2018Vanguard Group Inc1,078,053$3.33M0.0%N/A2.656%Search for SEC Filing on Google Icon
11/23/2018Vanguard Group Inc.1,078,053$3.33M0.0%N/A2.656%Search for SEC Filing on Google Icon
11/14/2018Sphera Funds Management LTD.1,131,819$3.50M0.4%+2.6%2.788%Search for SEC Filing on Google Icon
11/13/2018Granite Point Capital Management L.P.400,010$1.24M0.1%-46.7%0.986%Search for SEC Filing on Google Icon
11/9/2018FMR LLC565,500$1.75M0.0%-35.7%1.394%Search for SEC Filing on Google Icon
8/15/2018Millennium Management LLC225,000$0.93M0.0%N/A0.829%Search for SEC Filing on Google Icon
8/15/2018Nexthera Capital LP298,873$1.24M0.2%N/A1.101%Search for SEC Filing on Google Icon
8/15/2018Orbimed Advisors LLC5,193,946$21.56M0.3%N/A19.131%Search for SEC Filing on Google Icon
8/10/2018FMR LLC879,100$3.65M0.0%N/A2.166%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aerpio Pharmaceuticals logo
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing compounds that activate Tie2 for the treatment of ocular disease and vascular stabilization. The company's lead product candidate is razuprotafib, a small molecule inhibitor of vascular endothelial protein tyrosine phosphatase , which has completed phase IIb clinical trial for the treatment of non-proliferative diabetic retinopathy, as well as has completed phase II clinical trial for the treatment of patients with open angle glaucoma/ocular hypertension. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications, including nephropathy and diabetic macular edema; and bispecific antibody for the treatment for wet age-related macular degeneration and DME through intravitreal injection. Aerpio Pharmaceuticals, Inc. has a licensing and collaboration agreement with Gossamer Bio, Inc. for the development and commercialization of GB004, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed Phase 1b clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio.
Read More on Aerpio Pharmaceuticals

Today's Range

Now: $1.83
$1.81
$1.84

50 Day Range

MA: $1.52
$1.03
$2.22

52 Week Range

Now: $1.83
$0.95
$2.50

Volume

10,030 shs

Average Volume

4,206,482 shs

Market Capitalization

$86.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Who are the company insiders with the largest holdings of Aerpio Pharmaceuticals?

Aerpio Pharmaceuticals' top insider investors include:
  1. Joseph H Gardner (President)
  2. Orbimed Advisors Llc (Major Shareholder)

Who are the major institutional investors of Aerpio Pharmaceuticals?

Aerpio Pharmaceuticals' top institutional investors include:
  1. Ikarian Capital LLC — 5.60%
  2. EcoR1 Capital LLC — 4.38%
  3. Renaissance Technologies LLC — 4.10%
  4. Acadian Asset Management LLC — 4.04%
  5. Parkman Healthcare Partners LLC — 2.12%
  6. Scion Asset Management LLC — 2.11%

Which major investors are selling Aerpio Pharmaceuticals stock?

Within the previous quarter, ARPO stock was sold by these institutional investors:
  1. Virtu Financial LLC

Which major investors are buying Aerpio Pharmaceuticals stock?

In the previous quarter, ARPO stock was acquired by institutional investors including:
  1. Ikarian Capital LLC
  2. EcoR1 Capital LLC
  3. Opaleye Management Inc.
  4. Scion Asset Management LLC
  5. Parkman Healthcare Partners LLC
  6. Acadian Asset Management LLC
  7. Price T Rowe Associates Inc. MD
  8. Renaissance Technologies LLC
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021